ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Crinetics Pharmaceuticals, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -237.35% of over the last 5 years
2
Positive results in Mar 26
- NET SALES(HY) Higher at USD 16.89 MM
- NET PROFIT(HY) Higher at USD -250.66 MM
- RAW MATERIAL COST(Y) Fallen by -154.91% (YoY)
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 22.37%, its profits have fallen by -55.9%
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Crinetics Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Crinetics Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Crinetics Pharmaceuticals, Inc.
22.37%
-0.31
58.84%
S&P 500
19.75%
1.50
13.19%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
54.14%
EBIT Growth (5y)
-237.35%
EBIT to Interest (avg)
-198.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.55
EV to EBIT
-4.85
EV to EBITDA
-4.88
EV to Capital Employed
-85.41
EV to Sales
325.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-46.90%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
NET SALES(HY)
Higher at USD 16.89 MM
NET PROFIT(HY)
Higher at USD -250.66 MM
RAW MATERIAL COST(Y)
Fallen by -154.91% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 3.53 times
DEBTORS TURNOVER RATIO(HY)
Highest at 2.78 times
-12What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -414.17 MM
PRE-TAX PROFIT(Q)
Fallen at -32.11%
NET PROFIT(Q)
Fallen at -32.11%
Here's what is working for Crinetics Pharmaceuticals, Inc.
Net Sales
At USD 16.89 MM has Grown at 4,580.06%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Sales
Higher at USD 16.89 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Inventory Turnover Ratio
Highest at 3.53 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 2.78 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -154.91% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 1.16 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Crinetics Pharmaceuticals, Inc.
Operating Cash Flow
Lowest at USD -414.17 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Pre-Tax Profit
Fallen at -32.11%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Fallen at -32.11%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
